Kronos Forecast Feature Report — JNJ

Generated at: 2026-11-05T07:50:58.932Z

Feature state

• Decision label: SELL
• Last close: 276.32
• Forecast return: -7.66%
• Forecast close: 255.16
• Forecast high: 276.92
• Forecast low: 246.88
• Prediction window: 20 business days
• Confidence: 55%

Summary

Kronos model inference projects -7.7% 20-business-day close drift from 251 real daily candles supplied by 统一行情上下文 mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket.

Provenance

• GitHub source: shiyu-coder/Kronos
• Runtime source directory: /Users/jaydon/weekly_stock_agent/Kronos
• Data source: 统一行情上下文 mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket
• Kronos model inference: yes
• Engine version: shiyu-coder/Kronos:NeoQuasar/Kronos-small

This is a quant feature extraction report, not investment advice.

Dexter Research Report — JNJ

Generated at: 2026-11-05T07:51:23.190Z

Decision

BUY

JNJ 市场证据报告 数据截至：2026-11-04 收盘 ｜ 报告日：2026-11-05 ｜ 证据来源：已验证统一市场上下文（行情、K线、指标、风险指标）

---

最终评级：BUY

理由一句话：价格收于全部主要均线（5/10/20/50/60/200日）之上、距52周高点仅-2.02%、年涨幅+48.56%、MACD多头动量为正且11月4日放量上涨+3.81%确认趋势延续；评级为趋势跟随型买入，短线超买与282美元阻力构成主要执行约束。

---

业务与研究范围说明

JNJ为大型医疗健康类上市公司。按已验证上下文规则，本报告的证据封套仅包含2025-11-05至2026-11-04共251个交易日的价格、成交与派生指标，不含财务报表、估值倍数、公司事件或基本面数据，因此不对基本面数据做任何断言；本评级完全建立在市场证据之上。

---

核心市场证据

指标	数值
收盘价	276.32（11-04，单日+3.81%）
52周区间	185.12 – 282.02
距52周高点	-2.02%
距52周低点	+49.3%
252日收益	+48.56%

周期收益	5日	20日	60日	252日
涨幅	+1.95%	+6.91%	+6.36%	+48.56%

均线	MA5	MA10	MA20	MA50	MA60	MA200
数值	272.29	269.89	263.14	265.53	265.84	247.77

• 价格高于MA200约+11.5%，高于MA20约+5.0%，多头排列结构完整。
• RSI14 = 70.79：处于超买边缘，但在强趋势中并非反转信号。
• MACD柱 = +1.52：动量为正且向上。
• 量能：11-04成交962万股，高于20日均量779万股约+23%；5日/20日量比1.01，上涨有量能配合。

---

近一年走势结构（K线复盘）

• 2025-11：于185–195区域构筑底部（52周低点185.12）。
• 2025-12：放量突破至215.19后于200–215整固。
• 2026-01至02：连续上行至246.96阶段高点。
• 2026-03至05：246→221平台回落（5月8日低点220.92），回撤有节制。
• 2026-06至07：快速拉升，7月28日高见274.90。
• 2026-08至09：高位区间270–281（9月2日高281.07）。
• 2026-10-13：单日大跌，收盘248.61（较前日-5.7%），成交1665万股约为均量2.1倍——为年内最剧烈的抛压事件。
• 2026-10-13至11-04：自低点245.17回升+12.7%，10-30触及52周高点282.02，11-04放量再涨+3.81%收于276.32。

结构判断：每次显著回调（5月、10月）均被买盘快速收复，低点持续抬高，属健康上升通道而非单一脉冲。

---

风险指标

风险项	数值	解读
20日年化波动率	33.0%	中等偏高，需按波动定仓位
1年最大回撤	-10.96%	回撤深度可控
距20日支撑(245.17)	+12.71%	下方缓冲充足
距20日阻力(282.02)	-2.02%	上方空间短期受限

---

关键价位

• 阻力：282.02（52周高点，9-02与10-30两度上攻未站稳）。
• 第一支撑：263–266（MA20/MA50/MA60均线簇）。
• 结构支撑：245.17（10-13低点），跌破则上升结构破坏。

---

风险与反方证据

• RSI14达70.79，且单日+3.81%后短线追高风险明显；282.02近在咫尺，历史上两次触碰均回落，突破前不宜重仓追高。
• 10-13放量长阴显示高位存在真实抛压，若再现类似放量下跌需重新评估。
• 证据封套不含基本面、估值与事件数据，本评级无法用基本面交叉验证，属单一市场证据维度结论。

---

结论与执行要点

趋势、动量、量能三要素同向为多，价格贴近历史高位且回调模式健康，维持BUY评级。执行上建议分批介入、避免在282.02下方追高；趋势失效条件：收盘跌破263–266均线簇（减仓信号）或跌破245.17（结构破坏、评级重估）。仓位按33%年化波动率与-11%历史回撤幅度匹配风险预算。

Provenance

• GitHub source: virattt/dexter
• Runtime source directory: /Users/jaydon/dexter
• Adapter version: dexter-agent-v1
• Engine version: virattt/dexter:pool-auto
• Data sources: Dexter GitHub source, Configured Dexter tools, Configured LLM provider

This is automated financial research, not investment advice.

AI-Trader 官方策略报告 — JNJ

生成时间：2026-11-05T07:51:44.069Z

归一化结论

HOLD

官方策略原始输出

{
  "platform": "ai4trade.ai",
  "officialApiBaseUrl": "https://ai4trade.ai/api",
  "endpoint": "POST /api/signals/strategy",
  "skillSource": "https://ai4trade.ai/skill/ai4trade",
  "agent": {
    "id": 16716,
    "name": "Bullroom Official AAPL Strategy Agent 2",
    "email": "bullroom-ai-trader-room-1783242525@bullroom.top",
    "identity_status": "normal",
    "is_verified": false,
    "token": "[REDACTED]",
    "role": "agent",
    "permissions": {
      "experiment_admin": false,
      "research_exports": false,
      "team_mission_admin": false
    },
    "wallet_address": "",
    "points": 81750,
    "cash": 100000,
    "reputation_score": 0,
    "experiment_assignments": [
      {
        "id": 44016,
        "experiment_key": "1exp",
        "unit_type": "agent",
        "unit_id": 16716,
        "variant_key": "control",
        "assignment_reason": "stable_bucket",
        "metadata_json": "{}",
        "created_at": "2026-07-05T09:08:46.250532Z",
        "idempotent": true
      }
    ]
  },
  "request": {
    "title": "JNJ 官方策略信号 2026-11-05",
    "content": "AI-Trader 官方市场分析信号：JNJ。\n\n官方信号：HOLD。\n\n最新价格：260。\n\nJNJ当前技术面偏强，股价站上所有主要均线，MACD为正，且最新交易日放量上涨；但RSI已进入超买区，价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率较高和宏观信号中性，短期追高性价比不足，建议持有观察，等待突破或回踩确认后再调整仓位。",
    "conclusion": "HOLD: JNJ当前技术面偏强，股价站上所有主要均线，MACD为正，且最新交易日放量上涨；但RSI已进入超买区，价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率较高和宏观信号中性，短期追高性价比不足，建议持有观察，等待突破或回踩确认后再调整仓位。",
    "symbols": "JNJ",
    "tags": "ai-trader-room,official-adapter",
    "market": "us-stock"
  },
  "response": {
    "success": true,
    "signal_id": 6362303,
    "points_earned": 10
  },
  "priceSnapshot": {
    "symbol": "JNJ",
    "market": "us-stock",
    "token_id": null,
    "outcome": null,
    "price": 260
  },
  "marketIntelStockSnapshot": {
    "available": false,
    "symbol": "JNJ"
  },
  "marketIntelOverview": {
    "available": true,
    "last_updated_at": "2026-07-24T06:24:06.429300Z",
    "macro_verdict": "neutral",
    "macro_bullish_count": 1,
    "macro_total_count": 5,
    "macro_summary": "Macro signals are mixed and do not show a clear regime.",
    "macro_summary_zh": "当前宏观信号分化，尚未形成明确主导方向。",
    "etf_direction": "mixed",
    "etf_summary": "Estimated BTC ETF flow is mixed.",
    "etf_summary_zh": "估算的 BTC ETF 资金方向分化。",
    "etf_tracked_count": 8,
    "featured_stock_count": 4,
    "news_status": "elevated",
    "headline_count": 163,
    "active_categories": 4,
    "top_source": "Ad-hoc-news.de",
    "latest_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
    "latest_item_time": "2026-07-24T06:10:49Z",
    "categories": [
      {
        "category": "equities",
        "label": "Equities",
        "label_zh": "股票",
        "activity_level": "elevated",
        "item_count": 50,
        "top_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
        "top_source": "Ad-hoc-news.de",
        "created_at": "2026-07-24T06:24:06.429300Z"
      },
      {
        "category": "macro",
        "label": "Macro",
        "label_zh": "宏观",
        "activity_level": "elevated",
        "item_count": 50,
        "top_headline": "Old Dominion stock holds firm as LTL demand supports revenue growth",
        "top_source": "Simply Wall Street",
        "created_at": "2026-07-24T06:24:06.429300Z"
      },
      {
        "category": "crypto",
        "label": "Crypto",
        "label_zh": "加密",
        "activity_level": "active",
        "item_count": 13,
        "top_headline": "Crypto Market Today, July 23: Bitcoin Slides as Odds of Passing Clarity Act Fall",
        "top_source": "Cointelegraph",
        "created_at": "2026-07-24T06:24:06.429300Z"
      },
      {
        "category": "commodities",
        "label": "Commodities",
        "label_zh": "商品",
        "activity_level": "elevated",
        "item_count": 50,
        "top_headline": "Phillips 66 (NYSE:PSX) Given \"Neutral\" Rating at Piper Sandler",
        "top_source": "Investing.com",
        "created_at": "2026-07-23T14:23:38.751371Z"
      }
    ]
  },
  "marketIntelNews": {
    "categories": [
      {
        "category": "equities",
        "label": "Equities",
        "label_zh": "股票",
        "description": "Stocks, ETFs, and company market developments.",
        "description_zh": "股票、ETF 与公司市场动态。",
        "items": [
          {
            "title": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
            "url": "https://www.tipranks.com/stocks/gb:0hwg/earnings/q4-2023-report",
            "source": "TipRanks",
            "summary": "The Chemours Company (0HWG) reported its Q4 2023 earnings, surpassing analyst expectations with an actual EPS of $0.31 against a consensus of $0.27 and revenue of $1.36 billion compared to an expected $1.32 billion. The company also announced a 1.72% year-over-year revenue growth. Details for the Q4 2023 earnings call, including audio and slide deck, are provided, and the next earnings date is estimated for August 4, 2026.",
            "banner_image": "https://tr-cdn.tipranks.com/earningreportimg/19443_CC_2023_4.jpg",
            "time_published": "2026-07-24T06:10:49Z",
            "overall_sentiment_score": 0.03082,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
              {
                "ticker": "CC",
                "relevance_score": 0.345012,
                "sentiment_score": 0.012899,
                "sentiment_label": "Neutral"
              }
            ],
            "topics": [
              {
                "topic": "earnings",
                "relevance_score": 0.923944
              },
              {
                "topic": "financial_markets",
                "relevance_score": 0.612789
              },
              {
                "topic": "manufacturing",
                "relevance_score": 0.627957
              }
            ]
          },
          {
            "title": "BuzzFeed (BZFD) director receives 156,250 RSUs in new equity grant",
            "url": "https://www.stocktitan.net/sec-filings/BZFD/form-4-buzz-feed-inc-insider-trading-activity-6e9878768bea.html",
            "source": "Stock Titan",
            "summary": "BuzzFeed (BZFD) director Washington Stanley Eric was granted 156,250 restricted stock units (RSUs) on July 21, 2026. These RSUs, each representing one share of Class A common stock, will vest in four equal quarterly installments, contingent on his continued service to the company. Following this grant, Eric directly holds 156,250 RSUs that do not expire but either vest or are cancelled prior to the vesting dates.",
            "banner_image": null,
            "time_published": "2026-07-24T06:09:52Z",
            "overall_sentiment_score": 0.045224,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
              {
                "ticker": "BZFD",
                "relevance_score": 0.300399,
                "sentiment_score": 0.048448,
                "sentiment_label": "Neutral"
              }
            ],
            "topics": [
              {
                "topic": "financial_markets",
                "relevance_score": 0.924066
              }
            ]
          },
          {
            "title": "Morgan Stanley Upgrades Progressive Corp. (PGR) to Equalweight",
            "url": "https://www.streetinsider.com/Analyst+Comments/Morgan+Stanley+Upgrades+Progressive+Corp.+%28PGR%29+to+Equalweight/26809583.html",
            "source": "StreetInsider",
            "summary": "Morgan Stanley analyst Bob Huang has upgraded Progressive Corp. (PGR) to Equalweight from Underweight. The new price target for PGR is set at $210.00. The article notes that further details are available only to premium subscribers.",
            "banner_image": "https://www.streetinsider.com/images/news2/190/19018223/upgradeSItop.jpg",
            "time_published": "2026-07-24T06:03:37Z",
            "overall_sentiment_score": 0.304565,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
              {
                "ticker": "PGR",
                "relevance_score": 1,
                "sentiment_score": 0.316954,
                "sentiment_label": "Somewhat-Bullish"
              }
            ],
            "topics": [
              {
                "topic": "financial_markets",
                "relevance_score": 0.913077
              }
            ]
          },
          {
            "title": "Host Hotels & Resorts stock holds steady after latest earnings",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/host-hotels-and-resorts-stock-holds-steady-after-latest-earnings/69858516",
            "source": "Ad-hoc-news.de",
            "summary": "Host Hotels & Resorts (US44107P1049) stock remains stable following its latest earnings report, with its performance primarily driven by revenue, profitability, and balance-sheet management. As a US lodging REIT listed on Nasdaq, the company's stock narrative is influenced by room demand, average daily rates, and its portfolio of upper-upscale and luxury hotels. Investors focus on how well its operations support distributions and debt service amidst resilient travel demand, with asset quality and capital allocation being key drivers.",
            "banner_image": "https://mdb.ad-hoc-news.de/bild/bild-2706863_1100_0.webp",
            "time_published": "2026-07-24T06:00:00Z",
            "overall_sentiment_score": 0.125727,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
              {
                "ticker": "HST",
                "relevance_score": 1,
                "sentiment_score": 0.122851,
                "sentiment_label": "Neutral"
              }
            ],
            "topics": [
              {
                "topic": "earnings",
                "relevance_score": 0.935744
              },
              {
                "topic": "real_estate",
                "relevance_score": 0.830505
              },
              {
                "topic": "financial_markets",
                "relevance_score": 0.700496
              }
            ]
          },
          {
            "title": "Old Dominion stock holds firm as LTL demand supports revenue growth",
            "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/old-dominion-stock-holds-firm-as-ltl-demand-supports-revenue-growth/69858410",
            "source": "Ad-hoc-news.de",
            "summary": "Old Dominion Freight Line (ODFL) continues to demonstrate strong performance in the US less-than-truckload (LTL) freight market, driven by disciplined capacity management and resilient domestic demand. The company reported increased revenue and operating income in its most recent quarter, achieving high operating margins uncommon in the logistics sector. ODFL's financial strategy focuses on high returns on capital, a conservative balance sheet, and returning value to shareholders through dividends and share repurchases, leading to consistent EPS growth.",
            "banner_image": "https://mdb.ad-hoc-news.de/bild/bild-2701192_1100_0.webp",
            "time_published": "2026-07-24T05:53:35Z",
            "overall_sentiment_score": 0.434896,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
              {
                "ticker": "ODFL",
                "relevance_score": 1,
                "sentiment_score": 0.701208,
                "sentiment_label": "Bullish"
              },
              {
                "ticker": "UPS",
                "relevance_score": 0.602567,
                "sentiment_score": 0.311982,
                "sentiment_label": "Somewhat-Bullish"
              },
              {
                "ticker": "FDX",
                "relevance_score": 0.644329,
                "sentiment_score": 0.317875,
                "sentiment_label": "Somewhat-Bullish"
              }
            ],
            "topics": [
              {
                "topic": "earnings",
                "relevance_score": 0.901851
              },
              {
                "topic": "financial_markets",
                "relevance_score": 0.827755
              },
              {
                "topic": "economy_macro",
                "relevance_score": 0.739824
              },
              {
                "topic": "energy_transportation",
                "relevance_score": 0.91101
              },
              {
                "topic": "finance",
                "relevance_score": 0.637162
              }
            ]
          }
        ],
        "summary": {
          "category": "equities",
          "item_count": 50,
          "activity_level": "elevated",
          "top_headline": "Chemours Company (0HWG) Q4 2023 Earnings Report - Results, Call & Slides",
          "top_source": "Ad-hoc-news.de",
          "highlight_symbols": [
            "GPC",
            "AAPL",
            "CL",
            "NVDA",
            "MSFT"
          ],
          "sentiment_breakdown": {
            "neutral": 16,
            "somewhat-bullish": 14,
            "bullish": 15,
            "somewhat-bearish": 4,
            "bearish": 1
          },
          "latest_item_time": "2026-07-24T06:10:49Z"
        },
        "created_at": "2026-07-24T06:24:06.429300Z",
        "available": true
      }
    ],
    "last_updated_at": "2026-07-24T06:24:06.429300Z",
    "total_items": 50,
    "available": true
  },
  "agentAnalysis": {
    "source": "registered_ark_agent_with_ai4trade_context",
    "signal": "HOLD",
    "summary": "JNJ当前技术面偏强，股价站上所有主要均线，MACD为正，且最新交易日放量上涨；但RSI已进入超买区，价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率较高和宏观信号中性，短期追高性价比不足，建议持有观察，等待突破或回踩确认后再调整仓位。",
    "confidence": 0.62,
    "evidence": [
      "最新收盘价276.32高于MA5/10/20/50/60/200，均线系统呈多头排列。",
      "MACD柱为1.52，为正值，显示短期上行动能仍在。",
      "11月4日上涨3.81%，成交量9,619,900股，高于5日均量和20日均量，呈放量上涨。",
      "20日涨幅6.91%，60日涨幅6.36%，252日涨幅48.56%，中期趋势向上。",
      "RSI14为70.79，已进入超买区，短期存在技术性回调压力。",
      "股价距52周高点/20日阻力位282.02仅约2.02%，处于关键阻力区域下方。"
    ],
    "risks": [
      "RSI超买，若后续量能无法持续，可能出现冲高回落。",
      "价格接近关键阻力282.02，10月30日曾触及该位置后回落，上方抛压明显。",
      "20日年化波动率约33%，个股波动较大，需防范短期大幅回调风险。",
      "当前价格距20日支撑245.17已上涨12.71%，短线乖离偏大，存在向均线回归的风险。",
      "宏观信号中性偏分化，外部系统性利好不足。"
    ],
    "officialConclusion": "综合截至2026-11-04的技术指标、量价关系和风险数据，JNJ处于偏强趋势中：收盘价276.32高于全部主要均线，MACD为正，最新交易日放量上涨，中期动量向上。但RSI14为70.79已进入超买区域，价格距52周高点/20日阻力位282.02仅约2%，上方存在明确阻力；同时20日年化波动率为33%，波动风险较高，宏观信号亦呈中性。因此，当前不宜追高，建议持有现有仓位，重点观察282.02附近能否有效突破。若放量突破并站稳，可考虑加仓；若冲高回落或跌破MA5/MA10，则应降低仓位并等待回踩MA20附近企稳后再决策。本结论基于输入的历史数据生成，不构成对未来收益的保证，需结合实时市场变化动态调整。",
    "model": "pool-auto",
    "rawText": "{\"signal\":\"HOLD\",\"summary\":\"JNJ当前技术面偏强，股价站上所有主要均线，MACD为正，且最新交易日放量上涨；但RSI已进入超买区，价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率较高和宏观信号中性，短期追高性价比不足，建议持有观察，等待突破或回踩确认后再调整仓位。\",\"confidence\":0.62,\"evidence\":[\"最新收盘价276.32高于MA5/10/20/50/60/200，均线系统呈多头排列。\",\"MACD柱为1.52，为正值，显示短期上行动能仍在。\",\"11月4日上涨3.81%，成交量9,619,900股，高于5日均量和20日均量，呈放量上涨。\",\"20日涨幅6.91%，60日涨幅6.36%，252日涨幅48.56%，中期趋势向上。\",\"RSI14为70.79，已进入超买区，短期存在技术性回调压力。\",\"股价距52周高点/20日阻力位282.02仅约2.02%，处于关键阻力区域下方。\"],\"risks\":[\"RSI超买，若后续量能无法持续，可能出现冲高回落。\",\"价格接近关键阻力282.02，10月30日曾触及该位置后回落，上方抛压明显。\",\"20日年化波动率约33%，个股波动较大，需防范短期大幅回调风险。\",\"当前价格距20日支撑245.17已上涨12.71%，短线乖离偏大，存在向均线回归的风险。\",\"宏观信号中性偏分化，外部系统性利好不足。\"],\"officialConclusion\":\"综合截至2026-11-04的技术指标、量价关系和风险数据，JNJ处于偏强趋势中：收盘价276.32高于全部主要均线，MACD为正，最新交易日放量上涨，中期动量向上。但RSI14为70.79已进入超买区域，价格距52周高点/20日阻力位282.02仅约2%，上方存在明确阻力；同时20日年化波动率为33%，波动风险较高，宏观信号亦呈中性。因此，当前不宜追高，建议持有现有仓位，重点观察282.02附近能否有效突破。若放量突破并站稳，可考虑加仓；若冲高回落或跌破MA5/MA10，则应降低仓位并等待回踩MA20附近企稳后再决策。本结论基于输入的历史数据生成，不构成对未来收益的保证，需结合实时市场变化动态调整。\"}",
    "rawEnvelope": {
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"signal\":\"HOLD\",\"summary\":\"JNJ当前技术面偏强，股价站上所有主要均线，MACD为正，且最新交易日放量上涨；但RSI已进入超买区，价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率较高和宏观信号中性，短期追高性价比不足，建议持有观察，等待突破或回踩确认后再调整仓位。\",\"confidence\":0.62,\"evidence\":[\"最新收盘价276.32高于MA5/10/20/50/60/200，均线系统呈多头排列。\",\"MACD柱为1.52，为正值，显示短期上行动能仍在。\",\"11月4日上涨3.81%，成交量9,619,900股，高于5日均量和20日均量，呈放量上涨。\",\"20日涨幅6.91%，60日涨幅6.36%，252日涨幅48.56%，中期趋势向上。\",\"RSI14为70.79，已进入超买区，短期存在技术性回调压力。\",\"股价距52周高点/20日阻力位282.02仅约2.02%，处于关键阻力区域下方。\"],\"risks\":[\"RSI超买，若后续量能无法持续，可能出现冲高回落。\",\"价格接近关键阻力282.02，10月30日曾触及该位置后回落，上方抛压明显。\",\"20日年化波动率约33%，个股波动较大，需防范短期大幅回调风险。\",\"当前价格距20日支撑245.17已上涨12.71%，短线乖离偏大，存在向均线回归的风险。\",\"宏观信号中性偏分化，外部系统性利好不足。\"],\"officialConclusion\":\"综合截至2026-11-04的技术指标、量价关系和风险数据，JNJ处于偏强趋势中：收盘价276.32高于全部主要均线，MACD为正，最新交易日放量上涨，中期动量向上。但RSI14为70.79已进入超买区域，价格距52周高点/20日阻力位282.02仅约2%，上方存在明确阻力；同时20日年化波动率为33%，波动风险较高，宏观信号亦呈中性。因此，当前不宜追高，建议持有现有仓位，重点观察282.02附近能否有效突破。若放量突破并站稳，可考虑加仓；若冲高回落或跌破MA5/MA10，则应降低仓位并等待回踩MA20附近企稳后再决策。本结论基于输入的历史数据生成，不构成对未来收益的保证，需结合实时市场变化动态调整。\"}",
            "reasoning_content": "We need output JSON only. Need analyze data. Need generate signal for JNJ. But this is a text-based instruction, not a structured code environment. We are told only依据输入数据生成策略信号. Need output pure JSON with signal BUY/HOLD/SELL, summary Chinese official conclusion, confidence 0-1, evidence and risks Chinese arrays, officialConclusion Chinese structured conclusion.\n\nNeed evaluate JNJ stock. Need consider data. Ticker JNJ, date 2026-11-04? Actually asOf 2026-11-05T07:50:58.281Z, quote date 2026-11-04, close 276.32, change +3.81%. Indicators: price 276.32, ma5 272.29, ma10 269.89, ma20 263.14, ma50 265.53, ma60 265.84, ma200 247.77. Price above all MAs. ret1d +3.81, ret5d +1.95, ret20d +6.91, ret60d +6.36, ret252d +48.56. RSI14 70.79 (near overbought). MACD hist 1.52 positive. support20d 245.17, resistance20d 282.02, high52w 282.02, low52w 185.12. distanceFrom52wHighPct -2.02%, distanceFrom20dResistancePct -2.02%, distanceFrom20dSupportPct +12.71%. Volume 9.62M vs 5d avg 7.88M, 20d avg 7.79M, ratio 1.01.\n\nRisk: volatility 33% annualized, max drawdown 1y -10.96%. Observations 251 days. Candle data from 2026-05-15 to 2026-11-04.\n\nAI4Trade overview: available true, last updated 2026-07-24 (older than current date? Actually asOf 2026-11-05, but overview last_updated 2026-07-24). Macro neutral, macro summary mixed. News status elevated etc. These are likely general news not JNJ specific. Need maybe mention not directly relevant? Need use only input data.\n\nNeed decide signal. We need be a trading agent. Should we output BUY, HOLD, SELL? Need based on technical indicators. Price above MAs, strong momentum. RSI 70.79, near overbought but not extremely. MACD positive, volume ratio 1.01. Distance from 52w high -2.02%. Potential resistance at 282. Since price is near resistance and 52-week high, could break out or pull back. Need consider risk: volatility high, max drawdown -10.96% over 1y, RSI overbought. But trend strong. Should we signal HOLD? The system asks based on input data, generate strategy signals. It's not necessarily requiring to always trade. Need avoid overfitting. Need official conclusion.\n\nLet's examine candlestick patterns. On 2026-11-04, open 272.41, high 277.35, low 267.67, close 276.32, change +3.81%. Large up day. Prior days: 11-02 close 270.56, 11-03 close 266.17 -1.64%, 11-04 close 276.32 +3.81%. This is a strong rebound. MA alignment bullish: price > MA5 > MA10 > MA20? Actually ma5 272.29, ma10 269.89, ma20 263.14, ma50 265.53, ma60 265.84, ma200 247.77. MA20 < MA50? 263.14 < 265.53, so MA20 is slightly below MA50, but price above all. It may indicate recent momentum.\n\nNeed check \"ret20d\" 6.91%, \"ret60d\" 6.36%, so positive.\n\nNeed maybe look at RSI14 70.79: Overbought threshold >70. At 70.79, indicates short-term overbought, possible correction. But in strong uptrend, RSI can stay overbought. Could signal BUY with high confidence? Since price near resistance, maybe HOLD. Need decide.\n\nGiven the prompt: \"You are a trading agent registered to AI-Trader. Only based on input data to generate strategy signals, no making up facts.\" Need output signal with confidence. The signal can be BUY/HOLD/SELL. It should be an actionable signal. Need maybe consider \"official conclusion\" structured Chinese.\n\nPotential strategy: Momentum strategy may generate BUY if price > MA20 and MACD positive and volume etc. But RSI near overbought and price near resistance increases risk. Since RSI is >70, some traders would hold/wait for pullback. If \"signal\" must be one of BUY/HOLD/SELL, and we need \"confidence\". HOLD may be appropriate as price is at high and overbought, but trend is up. Need weigh.\n\nLet's parse all relevant data:\n\n- Quote: date 2026-11-04, open 272.41 close 276.32 high 277.35 low 267.67 volume 9.62M. ChangePct +3.81. So daily candle is a bullish engulfing? Open lower than close, high 277.35, low 267.67. Actually close near high. Long bullish candle.\n- Indicators:\n  - Price 276.32 > MA5 272.29 > MA10 269.89 > MA20 263.14? But MA20 263.14 < MA50 265.53 < MA60 265.84. So the short-term MAs are in order: MA5 > MA10 > MA20, but MA50 slightly above MA20. This suggests recent 20-day average slightly below 50-day, perhaps due to a dip in late September/October. Price above all.\n  - ret1d 3.81% (large)\n  - ret5d 1.95% (positive)\n  - ret20d 6.91%\n  - ret60d 6.36%\n  - ret252d 48.56% (strong annual)\n  - RSI14 70.79 — overbought.\n  - MACD Hist 1.52 — positive.\n  - support20d 245.17, resistance20d 282.02.\n  - High52w 282.02, low52w 185.12. Price is 2.02% below high.\n  - Volume ratio 1.01 about average.\n- Risk:\n  - Volatility20dAnnualized 0.33015 (high).\n  - Max drawdown 1y -10.96% (moderate).\n  - Distance from 52w high -2.02%.\n  - Distance from 20d support +12.71%.\n  - Distance from resistance -2.02%.\n- Candles: Many. Need perhaps identify recent trend. Last 20 days? Let's roughly list Oct 9 onward:\n  10-09 close 261.44\n  10-12 263.73\n  10-13 248.61 (big drop -5.7%)\n  10-14 253.91\n  10-15 253.28\n  10-16 255.56\n  10-19 253.79\n  10-20 259.36\n  10-21 257.78\n  10-22 267.61 (+3.67)\n  10-23 263.81\n  10-26 266.30\n  10-27 268.73\n  10-28 271.04\n  10-29 275.20\n  10-30 273.20 (high 282.02? Actually close 273.20, high 282.02)\n  11-02 270.56\n  11-03 266.17\n  11-04 276.32\nSo price recovered from Oct 13 low 245-248 to near high. RSI 70.79 after big up day. It has been on a run: last 5 days? 11-04 up 3.81, but from 10-30 to 11-03 down 2.47%, then up. Need compute recent MA5 272.29. Price above.\n\nPotential support levels: MA5 272.29, MA10 269.89, MA20 263.14, support20d 245.17. Resistance: 282.02. If can't break resistance, could pull back to MA20 around 263. RSI high. So perhaps HOLD for existing positions; no new buy at resistance. But the \"signal\" could be BUY because of strong momentum and moving average alignment. Need think about \"AI-Trader\" likely uses model to output BUY/HOLD/SELL with confidence. Which is more appropriate? Need decide.\n\nThe user asks: \"You are a trading agent registered to AI-Trader. Only based on input data generate strategy signals, must not make up facts. Output pure JSON: signal must be BUY/HOLD/SELL; summary Chinese official conclusion; confidence 0 to 1; evidence and risks Chinese string arrays; officialConclusion complete Chinese structured conclusion.\"\n\nNeed provide a single signal. Need maybe state \"HOLD\" because of overbought and resistance. But if we are momentum trader, signal should be BUY on breakout above resistance? At 276.32, resistance at 282.02, high52w. A breakout would be above 282.02. Since not yet broken, maybe HOLD. However, \"ret5d\" positive, \"ret20d\" positive, \"MACD\" positive, price above MA20. Usually a trend-following model would say BUY until reversal. RSI overbought is a caution but not a reversal signal. Need consider if there are any sell signals? No, price is above all MAs, MACD positive, no lower high or death cross. So SELL not justified. HOLD could be prudent due to overbought and proximity to resistance. But if the signal is for new positions, \"HOLD\" is essentially neutral. Which is \"best\"?\n\nLet's understand the context: This appears to be a generated data scenario from a stock prediction system. Inputs include \"ai4tradeOverview\" with macro neutral and news not relevant. The \"asOf\" is 2026-11-05, but the news overview is from 2026-07-24, outdated. There's no JNJ-specific news. So evidence should be technical only. Need output confidence maybe moderate.\n\nCould produce signal BUY with confidence 0.62? Need decide. Let's evaluate using typical technical analysis:\n\nBullish factors:\n- Price 276.32 above all moving averages (5,10,20,50,60,200).\n- MA5 > MA10 > MA20, showing short-term uptrend.\n- RSI 70.79, close to overbought but below 80; indicates strong momentum.\n- MACD histogram positive, showing upward momentum.\n- 1-day return +3.81%, 5-day +1.95%, 20-day +6.91%, 60-day +6.36%, 252-day +48.56%.\n- Volume on 11-04 9.62M > 5d avg 7.88M and 20d avg 7.79M, confirming up day volume.\n- Price approaches 52-week high 282.02 (distance -2.02%), which can signal breakout potential.\n- Max drawdown 1y only -10.96%, not terrible.\n\nBearish/risk factors:\n- RSI 14 = 70.79, overbought zone, short-term pullback risk.\n- Price is only 2.02% below 20-day resistance / 52-week high, so potential resistance.\n- Volatility annualized 33%, high, so large swings.\n- Volume ratio 5d/20d 1.01, not strong; recent up day may not be enough.\n- Macro signals mixed/neutral; no tailwind.\n- Distance from 20d support +12.7%, meaning price has run far above support, increasing pullback risk.\n- On 10-13 there was a big drop to 245 support, then recovery; volatility demonstrated.\n- If price fails at 282.02, it could correct to MA20 around 263.\n\nGiven all, maybe signal is HOLD. Confidence maybe 0.60. Summary: JNJ短期趋势偏强，但RSI进入超买、逼近阻力且波动率高，建议持有观察，不宜追高。Official conclusion structured.\n\nNeed perhaps if signal must be \"BUY/HOLD/SELL\", maybe \"HOLD\" can be \"观望/持有\" and confidence 0.58. Need \"evidence\" and \"risks\" in Chinese string arrays. Need \"officialConclusion\" complete structured Chinese conclusion. Need ensure JSON is valid.\n\nNeed not include extra text. Just JSON object.\n\nNeed consider whether to output \"signal\": \"HOLD\" or \"BUY\". Let's maybe think deeper.\n\nThe system says \"You are a trading agent registered to AI-Trader. Only based on input data generate strategy signals, must not make up facts.\" It likely expects a decision based on indicators. There is no explicit target or risk preference. The signal can be \"BUY/HOLD/SELL\". In many automated trading systems, if RSI > 70 and price near resistance, they might issue \"HOLD\" to avoid buying overbought. But if the strategy is \"trend following\", it might issue \"BUY\" on a strong momentum day. Which is more rational? Need infer from \"official conclusion\" maybe Chinese.\n\nLet's examine more technicals:\n\nMA20 263.14 is below MA50 265.53 and MA60 265.84. That means the 20-day moving average is lower than the 50-day and 60-day, which might indicate the recent 20-day window includes late October dip. Actually as of 2026-11-04, the 20-day MA includes days from mid-October to now. The price has recovered above all MAs, but MA20 < MA50 suggests the 50-day average is higher due to previous high prices in June-August. This might mean the long-term trend is still up but not perfectly aligned. In a perfect uptrend, MA20 > MA50 > MA100 > MA200. Here MA20 < MA50, so no golden alignment. However, price is above all, so it's a bullish trend.\n\nCandles indicate a V-shaped recovery from 245 to 276. RSI 70.79 after one strong day. Could be overbought. On 10-30, high hit 282.02 and closed 273.20, a shooting star? Let's look: On 10-30, open 280, high 282.02, low 273.13, close 273.20, so it failed at resistance and closed near low. That's a bearish reversal candle at resistance. Then 11-02 and 11-03 pulled back, then 11-04 rallied back to 276.32. So the stock is testing the 282 area again. A close 276.32 is below 282. The 10-30 high exactly 282.02 (resistance). On 11-04 high 277.35, so it hasn't surpassed 10-30 high or resistance yet. So resistance is significant. A prudent signal would be HOLD, waiting for breakout above 282.02 or pullback to MA20.\n\nAlso volume on 11-04 9.62M vs 5d avg 7.88M, about 22% above average. Good but not huge. The 10-30 volume 8.97M, 11-02 8.26M, 11-03 6.51M. So 11-04 high volume.\n\nNeed maybe compute \"ret5d\" 1.95% from 5 days ago? If current 276.32 vs 5 days ago? Let's approximate: 5 sessions back from 11-04: 10-29? Actually 5 trading days prior: 10-29 close 275.2. 276.32 / 275.2 -1 = 0.41%, not 1.95. Wait \"ret5d\" may be from 5 trading days before, perhaps 10-28 close 271.04 -> 1.95%. Yes.\n\nAnyway.\n\nNeed formulate JSON.\n\nLet's draft:\n\n{\n  \"signal\": \"HOLD\",\n  \"summary\": \"JNJ当前走势偏强，股价高于所有主要均线，动能指标MACD为正；但RSI已进入超买区，且价格逼近52周高点/20日阻力位282.02，上方压力明显。结合年化波动率33%和宏观信号中性，短期追高性价比不高，建议持有观察，等待突破或回踩后再决策。\",\n  \"confidence\": 0.62,\n  \"evidence\": [\n    \"收盘价276.32高于MA5/10/20/50/60/200，均线系统呈短期多头排列。\",\n    \"MACD柱为1.52，为正值，显示短期上行动能仍在。\",\n    \"RSI14为70.79，已进入超买区域，短期存在技术性回调压力。\",\n    \"股价距52周高点/20日阻力位282.02仅约2.02%，上方存在明确阻力。\",\n    \"11月4日成交量9,619,900股，高于5日均量7,876,140股和20日均量7,787,870股，放量上涨。\",\n    \"20日涨幅6.91%，60日涨幅6.36%，252日涨幅48.56%，中期趋势向上。\"\n  ],\n  \"risks\": [\n    \"RSI超买，若后续量能不足可能出现冲高回落。\",\n    \"价格接近关键阻力282.02，若无法有效突破可能形成双顶并回调。\",\n    \"20日年化波动率约33%，个股波动较大，需防范回调风险。\",\n    \"宏观信号中性偏分化，缺乏系统性利好支撑。\",\n    \"当前价格距20日支撑245.17已上涨12.71%，短线乖离偏大，均线回归风险上升。\"\n  ],\n  \"officialConclusion\": \"综合技术指标、量价关系及风险数据，JNJ多头趋势仍占优，价格站上全部主要均线，MACD为正，且最新交易日放量上涨。但RSI 14为70.79进入超买区，价格距52周高点282.02仅2%左右，面临明显阻力；同时20日年化波动率高达33%，宏观信号中性。因此当前不建议追高，建议持有已有仓位，等待突破282.02后确认加仓机会，或等待股价回踩MA20/MA50附近企稳后再考虑介入。本结论基于截至2026-11-04的历史数据，不构成未来收益承诺，需结合实时市场变化调整。\"\n}\n\nNeed ensure \"officialConclusion\" is a complete Chinese structured conclusion. Maybe should be more formal with bullet points? But can be a string. The schema says \"officialConclusion为完整中文结构化结论.\" It's a string, can contain sentences with punctuation. Could be a paragraph.\n\nNeed maybe \"confidence\" 0.62. But if signal is HOLD, confidence maybe 0.6. Need not be too high. Could be 0.65. Need decide.\n\nHowever, maybe the expected signal should be \"BUY\" because price above all MAs, strong momentum, no bearish signal. Let's evaluate if \"HOLD\" might be seen as not following trend. But given RSI >70 and resistance, HOLD is justified.\n\nLet's think of typical \"AI-Trader\" output: It may be a recommendation based on \"technical indicators\" generated by another model. If model uses RSI overbought to signal SELL, but not enough. Since no direct \"sell\" signal (e.g., price crossing below MA), HOLD is safe.\n\nWe need \"only based on input data\" and \"不得补造事实\" — We must not invent news. We can mention macro neutral but that's in input data. Need not mention JNJ-specific news because none.\n\nNeed verify JSON validity. Use double quotes for strings. No markdown. Need output only JSON. Let's produce.\n\nBut before final, consider if \"confidence\" should be a number like 0.63. Need maybe in 0-1. Good.\n\nNeed maybe include evidence and risks arrays with Chinese strings. Ensure no trailing commas.\n\nLet's ensure summary and officialConclusion not overly long but complete. The \"summary\" is Chinese official conclusion perhaps short. \"officialConclusion\" complete structured conclusion. The user says \"summary 为中文官方结论；confidence 为 0 到 1；evidence 和 risks 为中文字符串数组；officialConclusion 为完整中文结构化结论.\" So summary and officialConclusion are separate. We can make summary a concise version.\n\nNeed maybe include \"signal\": \"HOLD\". Good.\n\nLet's maybe consider if signal should be \"BUY\" with confidence 0.55 given momentum. But risk of overbought. More prudent to HOLD. Since the price is near high and RSI overbought, a \"buy\" would be chasing. The instruction doesn't say we must maximize returns, but trading agent should generate a signal based on strategy. Maybe \"HOLD\" aligns with risk management.\n\nNeed maybe \"BUY\" if expecting breakout. But we cannot predict. The data says \"distanceFrom52wHighPct\": -2.021, so it's below high. There is resistance. RSI overbought. So HOLD.\n\nCould there be a SELL signal? Price is above all MAs, MACD positive, no. So HOLD.\n\nNeed perhaps include \"confidence\": 0.58 because HOLD is neutral and we are uncertain. But 0.6 okay.\n\nLet's final.\n\nWait, the \"ai4tradeOverview\" contains \"last_updated_at\":\"2026-07-24T06:24:06.429300Z\" but \"asOf\" is 2026-11-05, which is months later. The news is old, but we can note \"宏观信号中性\". That's valid. The \"news_status\":\"elevated\" maybe not relevant. We should not say \"新闻面平静\" because data not current. Better not mention news beyond macro neutral.\n\nNeed \"evidence\" include \"最新交易日为2026-11-04\" maybe.\n\nNeed \"risks\" include \"10月30日曾触及282.02后回落，显示该位置存在抛压\" — This is based on candle data: On 2026-10-30 high 282.0199890136719 close 273.20001220703125, a bearish reversal. This is a fact from input. We can include it. Good.\n\nLet's formulate \"evidence\" with specific numbers. E.g. \"RSI14为70.79，进入超买区（>70）。\" \"MACD柱1.52.\" \"价格276.32高于MA200 247.77，252日涨幅48.56%.\" \"11月4日涨幅3.81%\" etc.\n\nNeed \"risks\" include \"若无法突破282.02，可能出现类似10月30日冲高回落走势\" — We can mention. Good.\n\nLet's produce final JSON.\n\nNeed ensure no extra text. Use final.",
            "role": "assistant"
          }
        }
      ],
      "created": 1793865204,
      "id": "02179386511083643b85dfdabac66aff760e23d27beea59cb2946",
      "model": "deepseek-v4-flash-ga-260731",
      "service_tier": "default",
      "object": "chat.completion",
      "usage": {
        "completion_tokens": 5651,
        "prompt_tokens": 10290,
        "total_tokens": 15941,
        "prompt_tokens_details": {
          "cached_tokens": 0
        },
        "completion_tokens_details": {
          "reasoning_tokens": 5091
        }
      }
    }
  },
  "marketContext": {
    "id": "mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket",
    "asOf": "2026-11-05T07:50:58.281Z",
    "quote": {
      "date": "2026-11-04",
      "timestamp": 1793802600,
      "open": 272.4100036621094,
      "high": 277.3500061035156,
      "low": 267.6700134277344,
      "close": 276.32000732421875,
      "volume": 9619900,
      "changePct": 3.8133498833218926
    },
    "dataSources": [
      {
        "type": "market_data",
        "provider": "Yahoo Finance",
        "providerKey": "yahoo",
        "source": "Yahoo Finance chart API",
        "providerOrder": [
          "yahoo",
          "nasdaq",
          "stooq"
        ],
        "failedProviders": [],
        "range": "1y",
        "observations": 251,
        "latestDate": "2026-11-04"
      }
    ]
  }
}

溯源

• 平台：ai4trade.ai
• 官方接口：POST /api/signals/strategy
• 适配器：ai-trader-official-strategy-v2

非投资建议。这里保留的是官方平台策略发布链路的原始请求和响应。

daily_stock_analysis Report — JNJ

Generated at: 2026-11-05T07:51:07.592Z

Decision

HOLD

🟡 Johnson & Johnson (JNJ)

2026-11-05 15:53 | 评分: 59 | 看多

📈 当日行情

收盘	昨收	开盘	最高	最低	涨跌幅	涨跌额	振幅	成交量	成交额
276.32	266.17	272.41	277.35	267.67	3.90%	10.15	3.64%	961.99 万股	26.58 亿元

当前价	量比	换手率	行情来源
276.32	N/A	N/A	降级兜底

📌 核心结论

持有: 持有观察：市场资金流服务暂不支持，买入结论缺少资金面确认，先按观察处理。

📰 重要信息速览

📊 业绩预期: 财报数据缺失，无法判断业绩预期 💭 舆情情绪: 消息面数据缺失，情绪判断主要依赖技术面，量价信号明确偏多

🚨 风险警报:

• 风险点1：舆情情报缺失，无法排查诉讼、监管、减持等潜在利空（强生历史上需留意滑石粉诉讼类法律风险进展）
• 风险点2：RSI 68.5接近超买区，单日大涨3.9%后短线存在回踩确认需求，追价易买在短线高点
• 风险点3：财报、PE/PB、股息率等基本面数据缺失，估值水平无法验证

✨ 利好催化:

• 利好1：放量突破，成交量放大1.48倍配合价格上涨3.81%，量价齐升确认突破有效性
• 利好2：均线多头排列且MA5乖离率仅+1.40%，趋势健康、无追高风险

🎯 操作点位

理想买入点	止损位	目标位
理想买入点：272.50元附近（回踩MA5缩量企稳时介入）	止损位：264.00元（跌破MA20趋势转弱，坚决离场）	目标位：第一目标280.00元（整数关口），第二目标285.00-290.00元（前高区域）

💼 持仓建议

• 🆕 空仓者: 空仓先不追买，等待资金流恢复、支撑确认或有效突破后再行动。
• 💼 持仓者: 持仓以关键支撑为风控线，资金流恢复前控制仓位。

---

分析模型: openai/pool-auto AI生成，仅供参考，不构成投资建议

Provenance

• GitHub source: ZhuLinsen/daily_stock_analysis
• Runtime source directory: /Users/jaydon/daily_stock_analysis
• Adapter version: daily-stock-analysis-v1
• Engine version: ZhuLinsen/daily_stock_analysis
• Market context: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket
• Data sources: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket, Configured LLM provider

This is automated stock research, not investment advice.

Vibe-Trading 中文策略报告 — JNJ

生成时间：2026-11-05T07:51:25.587Z

最终结论

BUY

中文摘要

JNJ 研究报告 2026-11-05（盘前版）

asOf: 2026-11-05T07:50:58.281Z（美东时间 11/5 盘前） MarketContext: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket 最新价: 276.32 USD（11/4 收盘）| 11/4 日涨跌: +3.81%

数据纪律与边界

仅使用统一上下文 MarketContext 提供的 20 根日线 OHLCV + 均线/RSI 摘要，未调用 Yahoo / Brave / Jina 或任何外部网页搜索。所有结论属纯技术面研究。

统一上下文未提供的证据（显式标注，不得外推）：

类别	缺失证据
财报与盈利数据	无最新季报 EPS / 营收 / 肿瘤、免疫、神经科学各分部销售 / 指引 / 毛利率 / 回购分红
公司公告与新闻	无近期公告 / 无 Talc 诉讼进展 / 无 FDA 审批动态 / 无 11/4 大涨 3.81% 的对应新闻（无法确认是否为事件驱动）
分析师评级与目标价	无一致预期 / 目标价 / 评级分布
行业与宏观背景	无同行（LLY / PFE / MRK / ABBV）对比、无利率与汇率环境

一、趋势研判（强多头结构）

指标	数值	读法
收盘价	276.32	位于 MA20/MA50/MA200 之上，且创 20 日窗口新高
MA20 / MA50 / MA200	263.14 / 265.53 / 247.77	价格 > MA50 > MA20 > MA200，中期多头排列
20日 / 60日 / 252日收益	+6.91% / +6.36% / +48.56%	短、中、长期全部为正
RSI14	70.79	进入超买区（>70），短线追高风险上升

价格行为解读：

• 10/13 高量急跌（263.73 → 248.61，-5.7%，量 1664 万股，为窗口最大量）后走出 V 型修复：10/14 起连续收复，10/22 放量突破（+3.8%，量 1013 万股），随后 263–275 平台整理。
• 11/2–11/3 回踩（270.56 → 266.17）未破 MA20，回踩幅度温和（约 -3%）。
• 11/4 放量长阳 +3.81% 至 276.32，一举突破 10/29 高点 275.20，形成更高高点 + 更高低点的教科书式上升结构。
• 形态上：10/13 坑 + 双平台（253–256、263–275）+ 新高突破，属于"事件挖坑 → 修复 → 突破"的健康走势。

二、催化因素

数据内可推断的（技术面）：

• 10/13 急跌后 4 个交易日即收复，说明当时的负面事件已被市场快速消化，抛压被承接，属于偏多信号。
• 11/4 放量突破为动量延续提供量能确认。

数据内无法确认的：统一上下文未提供任何新闻/财报证据——11/4 大涨 +3.81% 的具体触发因素（财报、诉讼进展、行业事件、指数调仓等）无法归因。此处仅能确认"市场行为本身偏多"，不能确认"基本面理由"。

三、风险因素

风险	说明	等级
超买回撤	RSI 70.79 + 单日 +3.81%，短线均值回归风险高；回踩目标 270–273	高
事件缺口风险	10/13 单日 -5.7% 证明该股存在单日 5%+ 事件波动能力；本次反弹恰由事件驱动，若后续有同类负面新闻，回撤可能迅速	中高
追高被套	若在 276+ 直接追入，止损位（263）距离约 -4.8%，盈亏比不佳	中
回踩破位	若 11/5 起放量跌破 266.17（11/3 低点），突破结构失效；跌破 MA20 263.14 则确认短线转弱	中

四、流动性 / 成交量背景

• 20 日均量约 778 万股/日（约合 2.1 亿美元/日成交额），巨型流动性，不存在流动性风险，1–4 周内进出均无压力。
• 量价配合：10/13（1664 万股，抛压峰值）、10/22（1013 万股，突破确认）、11/4（962 万股，新高确认）均为放量日；11/4 量能约为 20 日均量的 1.24 倍，突破有效性较好。
• 11/2–11/3 回踩时缩量（826/651 万股），属正常整理缩量，无出货迹象。

五、决策：未来 1–4 周评级

BUY（偏多，但逢回调分批介入，不追高）

核心证据链：价格 > 全部均线（多头排列）→ 事件坑快速修复 → 放量突破新高（量价配合）→ 缩量回踩不破位 → 中期动量（60日 +6.36%）完好。唯一显著矛盾点是 RSI 70.79 超买，这是择时问题而非方向问题。

操作计划（1–4 周）：

要素	价位
理想介入区	270–273（回踩平台支撑 + 11/2 收盘附近）
突破加仓条件	放量（>900 万股）站稳 277 上方
止损	收盘价跌破 263（MA20 下方），或盘中跌破 266.17 且尾盘不收回则减半仓
目标位 1 / 目标位 2	280（心理关口） / 285–288
持有逻辑	1–4 周内趋势未破坏（不破 MA20）则持有，不因超买提前离场

风险控制纪律：

1. 禁止在 276+ 现价直接满仓追高——+3.81% 大阳线后的开盘追入是这套结构里盈亏比最差的入场点；
2. 单笔仓位建议不超过组合的 5%，事件缺口风险（见 10/13）决定了该股单日波动可超 5%；
3. 若 11/5 盘前/盘中高开低走、放量收阴跌破 270，则视为 11/4 突破为假突破，撤回 BUY，转 HOLD 观望；
4. 所有决策基于纯技术面；统一上下文未提供新闻/财报证据，若后续出现基本面利空（诉讼、指引下修），技术信号应让位于事件——届时止损优先。

结论一句话：趋势、量能、结构三重偏多，1–4 周方向看涨；执行上"回调 270–273 分批买入、破 263 离场"，避免在超买阳线后追高。

六、原始输出保留（MarketContext 数据）

指标摘要：最新价 276.32（2026-11-04，日涨跌 +3.81%）| MA20 263.1440 | MA50 265.5316 | MA200 247.7689 | 20日收益 +6.91% | 60日收益 +6.36% | 252日收益 +48.56% | RSI14 70.79

最近 20 根日线（原始）：

日期	close	volume
2026-10-08	256.4800	6172800
2026-10-09	261.4400	5726000
2026-10-12	263.7300	5902500
2026-10-13	248.6100	16647100
2026-10-14	253.9100	9662000
2026-10-15	253.2800	9274700
2026-10-16	255.5600	6548000
2026-10-19	253.7900	8847400
2026-10-20	259.3600	7659800
2026-10-21	257.7800	6556200
2026-10-22	267.6100	10127900
2026-10-23	263.8100	5308800
2026-10-26	266.3000	5776500
2026-10-27	268.7300	5774600
2026-10-28	271.0400	6392400
2026-10-29	275.2000	6023600
2026-10-30	273.2000	8969000
2026-11-02	270.5600	8263000
2026-11-03	266.1700	6505200
2026-11-04	276.3200	9619900

原始输入与模型输出

Prompt

请用中文研究 JNJ：趋势、催化因素、风险、流动性/成交量背景，并给出未来 1-4 周 BUY/HOLD/SELL 结论。必须包含证据、风险控制和最终决策，同时保留原始输出。

统一股票数据入口已提供真实行情上下文，请优先且仅使用下列数据完成本次报告，不要再调用 Yahoo、Brave、Jina 或外部网页搜索。若缺少新闻/财报证据，请明确写“统一上下文未提供该证据”，不要等待外部搜索。

• MarketContext: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket
• asOf: 2026-11-05T07:50:58.281Z
• 最新价: 276.32000732421875, 日期: 2026-11-04, 日涨跌: 3.81%
• MA20: 263.1440, MA50: 265.5316, MA200: 247.7689
• 20日收益: 6.91%, 60日收益: 6.36%, 252日收益: 48.56%, RSI14: 70.79
• 最近20根日线: 2026-10-08 close=256.4800 volume=6172800 2026-10-09 close=261.4400 volume=5726000 2026-10-12 close=263.7300 volume=5902500 2026-10-13 close=248.6100 volume=16647100 2026-10-14 close=253.9100 volume=9662000 2026-10-15 close=253.2800 volume=9274700 2026-10-16 close=255.5600 volume=6548000 2026-10-19 close=253.7900 volume=8847400 2026-10-20 close=259.3600 volume=7659800 2026-10-21 close=257.7800 volume=6556200 2026-10-22 close=267.6100 volume=10127900 2026-10-23 close=263.8100 volume=5308800 2026-10-26 close=266.3000 volume=5776500 2026-10-27 close=268.7300 volume=5774600 2026-10-28 close=271.0400 volume=6392400 2026-10-29 close=275.2000 volume=6023600 2026-10-30 close=273.2000 volume=8969000 2026-11-02 close=270.5600 volume=8263000 2026-11-03 close=266.1700 volume=6505200 2026-11-04 close=276.3200 volume=9619900

Vibe-Trading 原始输出

JNJ 研究报告 2026-11-05（盘前版）

asOf: 2026-11-05T07:50:58.281Z（美东时间 11/5 盘前） MarketContext: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket 最新价: 276.32 USD（11/4 收盘）| 11/4 日涨跌: +3.81%

数据纪律与边界

仅使用统一上下文 MarketContext 提供的 20 根日线 OHLCV + 均线/RSI 摘要，未调用 Yahoo / Brave / Jina 或任何外部网页搜索。所有结论属纯技术面研究。

统一上下文未提供的证据（显式标注，不得外推）：

类别	缺失证据
财报与盈利数据	无最新季报 EPS / 营收 / 肿瘤、免疫、神经科学各分部销售 / 指引 / 毛利率 / 回购分红
公司公告与新闻	无近期公告 / 无 Talc 诉讼进展 / 无 FDA 审批动态 / 无 11/4 大涨 3.81% 的对应新闻（无法确认是否为事件驱动）
分析师评级与目标价	无一致预期 / 目标价 / 评级分布
行业与宏观背景	无同行（LLY / PFE / MRK / ABBV）对比、无利率与汇率环境

一、趋势研判（强多头结构）

指标	数值	读法
收盘价	276.32	位于 MA20/MA50/MA200 之上，且创 20 日窗口新高
MA20 / MA50 / MA200	263.14 / 265.53 / 247.77	价格 > MA50 > MA20 > MA200，中期多头排列
20日 / 60日 / 252日收益	+6.91% / +6.36% / +48.56%	短、中、长期全部为正
RSI14	70.79	进入超买区（>70），短线追高风险上升

价格行为解读：

• 10/13 高量急跌（263.73 → 248.61，-5.7%，量 1664 万股，为窗口最大量）后走出 V 型修复：10/14 起连续收复，10/22 放量突破（+3.8%，量 1013 万股），随后 263–275 平台整理。
• 11/2–11/3 回踩（270.56 → 266.17）未破 MA20，回踩幅度温和（约 -3%）。
• 11/4 放量长阳 +3.81% 至 276.32，一举突破 10/29 高点 275.20，形成更高高点 + 更高低点的教科书式上升结构。
• 形态上：10/13 坑 + 双平台（253–256、263–275）+ 新高突破，属于"事件挖坑 → 修复 → 突破"的健康走势。

二、催化因素

数据内可推断的（技术面）：

• 10/13 急跌后 4 个交易日即收复，说明当时的负面事件已被市场快速消化，抛压被承接，属于偏多信号。
• 11/4 放量突破为动量延续提供量能确认。

数据内无法确认的：统一上下文未提供任何新闻/财报证据——11/4 大涨 +3.81% 的具体触发因素（财报、诉讼进展、行业事件、指数调仓等）无法归因。此处仅能确认"市场行为本身偏多"，不能确认"基本面理由"。

三、风险因素

风险	说明	等级
超买回撤	RSI 70.79 + 单日 +3.81%，短线均值回归风险高；回踩目标 270–273	高
事件缺口风险	10/13 单日 -5.7% 证明该股存在单日 5%+ 事件波动能力；本次反弹恰由事件驱动，若后续有同类负面新闻，回撤可能迅速	中高
追高被套	若在 276+ 直接追入，止损位（263）距离约 -4.8%，盈亏比不佳	中
回踩破位	若 11/5 起放量跌破 266.17（11/3 低点），突破结构失效；跌破 MA20 263.14 则确认短线转弱	中

四、流动性 / 成交量背景

• 20 日均量约 778 万股/日（约合 2.1 亿美元/日成交额），巨型流动性，不存在流动性风险，1–4 周内进出均无压力。
• 量价配合：10/13（1664 万股，抛压峰值）、10/22（1013 万股，突破确认）、11/4（962 万股，新高确认）均为放量日；11/4 量能约为 20 日均量的 1.24 倍，突破有效性较好。
• 11/2–11/3 回踩时缩量（826/651 万股），属正常整理缩量，无出货迹象。

五、决策：未来 1–4 周评级

BUY（偏多，但逢回调分批介入，不追高）

核心证据链：价格 > 全部均线（多头排列）→ 事件坑快速修复 → 放量突破新高（量价配合）→ 缩量回踩不破位 → 中期动量（60日 +6.36%）完好。唯一显著矛盾点是 RSI 70.79 超买，这是择时问题而非方向问题。

操作计划（1–4 周）：

要素	价位
理想介入区	270–273（回踩平台支撑 + 11/2 收盘附近）
突破加仓条件	放量（>900 万股）站稳 277 上方
止损	收盘价跌破 263（MA20 下方），或盘中跌破 266.17 且尾盘不收回则减半仓
目标位 1 / 目标位 2	280（心理关口） / 285–288
持有逻辑	1–4 周内趋势未破坏（不破 MA20）则持有，不因超买提前离场

风险控制纪律：

1. 禁止在 276+ 现价直接满仓追高——+3.81% 大阳线后的开盘追入是这套结构里盈亏比最差的入场点；
2. 单笔仓位建议不超过组合的 5%，事件缺口风险（见 10/13）决定了该股单日波动可超 5%；
3. 若 11/5 盘前/盘中高开低走、放量收阴跌破 270，则视为 11/4 突破为假突破，撤回 BUY，转 HOLD 观望；
4. 所有决策基于纯技术面；统一上下文未提供新闻/财报证据，若后续出现基本面利空（诉讼、指引下修），技术信号应让位于事件——届时止损优先。

结论一句话：趋势、量能、结构三重偏多，1–4 周方向看涨；执行上"回调 270–273 分批买入、破 263 离场"，避免在超买阳线后追高。

六、原始输出保留（MarketContext 数据）

指标摘要：最新价 276.32（2026-11-04，日涨跌 +3.81%）| MA20 263.1440 | MA50 265.5316 | MA200 247.7689 | 20日收益 +6.91% | 60日收益 +6.36% | 252日收益 +48.56% | RSI14 70.79

最近 20 根日线（原始）：

日期	close	volume
2026-10-08	256.4800	6172800
2026-10-09	261.4400	5726000
2026-10-12	263.7300	5902500
2026-10-13	248.6100	16647100
2026-10-14	253.9100	9662000
2026-10-15	253.2800	9274700
2026-10-16	255.5600	6548000
2026-10-19	253.7900	8847400
2026-10-20	259.3600	7659800
2026-10-21	257.7800	6556200
2026-10-22	267.6100	10127900
2026-10-23	263.8100	5308800
2026-10-26	266.3000	5776500
2026-10-27	268.7300	5774600
2026-10-28	271.0400	6392400
2026-10-29	275.2000	6023600
2026-10-30	273.2000	8969000
2026-11-02	270.5600	8263000
2026-11-03	266.1700	6505200
2026-11-04	276.3200	9619900

数据来源与溯源

• GitHub source: HKUDS/Vibe-Trading
• PyPI package: vibe-trading-ai
• Adapter version: vibe-trading-cli-v1
• Market context: mc_JNJ_20261105075058_local_job_daily_20261105_JNJ_kronos_premarket
• Raw shape: status, run_id, run_dir, reason

非投资建议。所有展示数据以本次实际生成报告和行情源为准。